---
title: "Zhong Yuan Bio-Technology Holdings Limited (ZHYBF.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ZHYBF.US.md"
symbol: "ZHYBF.US"
name: "Zhong Yuan Bio-Technology Holdings Limited"
industry: "Personal Care Products"
---

# Zhong Yuan Bio-Technology Holdings Limited (ZHYBF.US)

| Item | Detail |
|------|--------|
| Industry | Personal Care Products |
| Location | US Market |
| Website | [www.zhybiotech.com](https://www.zhybiotech.com) |

## Company Profile

Zhong Yuan Bio-Technology Holdings Limited engages in the development and marketing of nervonic acid-based health supplements in China. The company’s products include Neuro Enhancer nervonic acid oils, Muzhiyuan acer truncatum formula oils, Life’s NA candies, and seedlings of Acer Truncatum. In addi...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-19T04:30:14.000Z

**Overall: C (0.42)**

**Industry**: Personal Care Products

| Metric | Value |
|--------|-------|
| Industry Ranking | 44 / 58 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 37.03% |  |
| Net Profit YoY | 114.06% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 17.71 |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 2.28M |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -66.90% | E |
| Profit Margin | 13.27% | B |
| Gross Margin | 90.94% | A |

#### Growth Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 37.03% | A |
| Net Profit YoY | 114.06% | A |
| Total Assets YoY | 48.48% | A |
| Net Assets YoY | 67.93% | A |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 753.86% | B |
| OCF YoY | 37.03% | A |

#### Operating Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.86 | B |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 106.91% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Zhong Yuan Bio-Technology Holdings Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-66.90%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "13.27%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "90.94%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "A",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "37.03%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "114.06%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "48.48%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "67.93%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "753.86%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "37.03%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "B",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.86",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "106.91%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Niagen Bioscience (US.NAGE) | A | A | A | B | B | A |
| 02 | L'Oréal S.A. (US.LRLCY) | A | B | B | C | B | B |
| 03 | Beiersdorf (US.BDRFY) | B | C | B | B | B | B |
| 04 | Kao Corporation (US.KAOOY) | B | C | A | C | B | B |
| 05 | ELF Beauty (US.ELF) | B | B | B | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 7.55 | 2/56 | 117.20 | 7.55 | 7.55 |
| PB | -11.15 | 41/56 | - | - | - |
| PS (TTM) | 1.00 | 19/56 | 15.55 | 1.00 | 1.00 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/ZHYBF.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ZHYBF.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ZHYBF.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.